ArticleBioinformatics (Oxford, England)2025
A deep learning-based method for predicting the frequency classes of drug side effects based on multi-source similarity fusion.
Article in Bioinformatics (Oxford, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Revolutionizing drug discovery from natural products: The roles of artificial intelligence and multi-omics in accelerating innovation.Acta pharmaceutica Sinica. B · 2026Article
- KAN-PROSPECT: a Kolmogorov-Arnold Networks-integrated framework for predicting the effects and adverse reactions of natural products via transfer learning.Scientific reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
motivationDrug side effects refer to harmful or adverse reactions that occur during drug use, unrelated to the therapeutic purpose. A core issue in drug side effect prediction is determining the frequency of these drug side effects in the population, which can guide patient medication use and drug development. Many computational methods have been developed to predict the frequency of drug side effects as an alternative to clinical trials. However, existing methods typically build regression models on five frequency classes of drug side effects and tend to overfit the training set, leading to boundary handling issues and the risk of overfitting.
resultsTo address this problem, we develop a multi-source similarity fusion-based model, named multi-source similarity fusion (MSSF), for predicting five frequency classes of drug side effects. Compared to existing methods, our model utilizes the multi-source feature fusion module and the self-attention mechanism to explore the relationships between drugs and side effects deeply and employs Bayesian variational inference to more accurately predict the frequency classes of drug side effects. The experimental results indicate that MSSF consistently achieves superior performance compared to existing models across multiple evaluation settings, including cross-validation, cold-start experiments, and independent testing. The visual analysis and case studies further demonstrate MSSF's reliable feature extraction capability and promise in predicting the frequency classes of drug side effects. AVAILABILITY AND IMPLEMENTATION: The source code of MSSF is available on GitHub (https://github.com/dingxlcse/MSSF.git) and archived on Zenodo (DOI: 10.5281/zenodo.15462041).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.